Diagnostic Value of DECT Scan Compared to Diagnostic Needle Aspiration
NCT03038386 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2019-03-19
Summary
Rationale: Gout is a disease with growing incidence and complexity due to increased life expectancy, co-morbidity and medication. The disease can be diagnosed by microscopy, demonstrating monosodium uric acid (MSU) in synovial fluid of the affected joint or in tophi (subcutaneous or peritendinous MSU depositions). In daily practice, however, the diagnosis is difficult to ascertain due to sampling error (no synovial fluid acquired because the needle was not exactly placed in the affected joint, or the location of the gout might have been extra-articular e.g. around tendons) or to a different cause of acute arthritis (e.g. infection, reactive arthritis). Recently, Dual Energy CT scan has become available. This technique allows the visualization and quantification of MSU. Although imaging modalities such as DECT show promise in the classification of gout, the studies to date have been small and have primarily involved people with established disease.
A study with cross-sectional design in which patients for whom the clinical questions "does this patient have gout?" are referred for participation may contribute to assess the value of DECT scan in diagnosing acute arthritis caused by gout.
Objective: Assessment of value of DECT scan in diagnosing acute arthritis, caused by gout.
Study design: Prospective Study population: Patients with acute mono or oligo arthritis without prior diagnosis, the rheumatologist has an indication for diagnostic needle aspiration.
Nature and extent of the burden and risks associated with participation, benefit and group relatedness: In current daily practice, patients with acute mono- or oligo-arthritis without prior diagnosis undergo a diagnostic aspiration of the affected joint. This can be done by blind aspiration or ultra sound guided aspiration depending on the judgement of the rheumatologist. The aspirated synovial fluid is then assessed by polarized microscopy to detect MSU crystals. The diagnostic value of DECT in acute gout attacks had not yet been established and is therefore not used in daily practice. In this study all patients undergo DECT scan to assess the value of DECT scan in diagnosing acute arthritis caused by gout. If the DECT scan demonstrates MSU depositions and the diagnosis of gout was not ascertained prior to DECT scanning by MSU crystals in the synovial fluid, then additional ultrasound guided aspiration will take place, with knowledge of DECT results, followed by repeat microscopy
Conditions
Interventions
- OTHER
-
Dual Energy CT
In this study all patients undergo DECT scan to assess the value of DECT scan in diagnosing acute arthritis caused by gout. If the DECT scan demonstrates MSU depositions and the diagnosis of gout was not ascertained prior to DECT scanning by MSU crystals in the synovial fluid, then additional ultrasound guided aspiration will take place, with knowledge of DECT results, followed by repeat microscopy
Sponsors & Collaborators
-
Meander Medical Center
lead OTHER
Principal Investigators
-
Ruth Klaasen, MD, PhD · Meander Medical Center
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-04-30
- Primary Completion
- 2018-12-31
- Completion
- 2019-06-30
Countries
- Netherlands
Study Locations
More Related Trials
-
Musculoskeletal Ultrasound in Asymptomatic Hyperuricemia
NCT02502565 ·Status: UNKNOWN
-
Improving Gout Care After an ED Visit
NCT06534554 ·Status: RECRUITING ·Phase: NA
-
Research and Development of a New Technology for Detection of Abnormal Excretion of Intestinal Uric Acid Involved in the Incidence of Gout
NCT04953533 ·Status: UNKNOWN
-
Effect of Febuxostat on Joint Damage in Hyperuricemic Subjects With Early Gout
NCT01078389 ·Status: COMPLETED ·Phase: PHASE2
-
Gout in the ED and Improving Research Participation
NCT04075903 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Gout Self-Monitoring Aiming to Reach Target
NCT03274063 ·Status: COMPLETED ·Phase: NA
-
Study of the Reliability of a Device (HumanSens Plus) Allowing Immediate Measurement Uric Acid in the Blood Obtained by Finger Tip Puncture.
NCT02671656 ·Status: WITHDRAWN
-
An Assessment of Chronic Synovial-Based Inflammation and Its Role With Serum Urate Levels.
NCT01112982 ·Status: COMPLETED ·Phase: PHASE4
-
Relation Between Blood Concentration of Colchicine and Response to Colchicine Treatment in Gout Flare
NCT03933007 ·Status: TERMINATED ·Phase: PHASE4
-
Nurse-Led Telehealth for Gout
NCT06971146 ·Status: RECRUITING ·Phase: NA
-
The Drug-Drug Interaction of SHR4640, Febuxostat and Colchicine in Patients With Gout
NCT03131583 ·Status: COMPLETED ·Phase: PHASE1
-
Prevalence of Abnormalities in Ultrasonography of Joint and Tendons in Patients With Gout
NCT05546593 ·Status: RECRUITING
-
The Efficiency and Safety of Sodium Bicarbonate on Uric Acid in Patients With Asymptomatic Hyperuricemia or Gout
NCT03306758 ·Status: UNKNOWN ·Phase: NA
-
Clinical Study of Genakumab for Injection in Patients With Acute Gout
NCT05328531 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of Oral Febuxostat in Subjects With Gout
NCT02082769 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With Gout
NCT01336686 ·Status: COMPLETED ·Phase: PHASE2
-
Hyperuricemia and Diabetic Nephropathy
NCT04799925 ·Status: UNKNOWN
-
Virtual Gout Clinic
NCT02790463 ·Status: COMPLETED ·Phase: NA
-
A Study of RDEA806 in Hyperuricemic Subjects With Symptomatic Gout
NCT00741442 ·Status: COMPLETED ·Phase: PHASE2
-
Gout Dose Response Study
NCT00955981 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Efficacy of Genakumab in Prevention of Acute Flares in Gout Patients Initiating Urate-lowering TherapyUrate-lowering (GenSci048-202)
NCT05936281 ·Status: COMPLETED ·Phase: PHASE2
-
A Exploratory Trial of WTX221 in Refractory Gout Patients
NCT05800041 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Low-dose Colchicine With or Without Stepwise Dose Titration of Febuxostat for Flare Prophylaxis in Gout
NCT04697602 ·Status: TERMINATED ·Phase: NA
-
Genetics of Hyperuricemia Therapy in Hmong
NCT02371421 ·Status: COMPLETED
-
The Influence of Urate-lowering Therapy on Sperm Quality of Male Gouty Patients:A Prospective Cohort Study
NCT04213534 ·Status: UNKNOWN